Although the EGFR-MAPK-PI3K pathway upregulates the expression, activity, and protein level of FOXC1 [8] (Figure 3), the how and why of FOXC1 being exclusively expressed in BLBC rather than in other breast-cancer molecular subtypes has yet to be answered. This evidence concerns the gene FOXC1 and breast cancer.